U.S. Hemoglobinopathies (Thalassemia, Sickle Cell Disease) Market Analysis Report 2024-2030: Ongoing Research into Novel Treatment Options & CRISPR-Cas9 Holds Promise for More Effective Therapies Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "U.S. Hemoglobinopathies Market Size, Share & Trends Analysis Report by Type (Thalassemia, Sickle Cell Disease), Diagnosis (Thalassemia, Sickle Cell...

Global Sickle Cell Disease Treatment Market Report 2024: Robust Expansions Projected by 2031 with AstraZeneca., Eli Lilly and Co, Bristol-Myers Squibb Spearheading Growth Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...

Sickle Cell Disease Market Forecast Reveals Insights up to 2032 with Epidemiological Trends and Advanced Treatment Approaches Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. A...

Sickle Cell Disease Treatment Market Trends Report 2023-2030, Featuring Profiles of Novartis, Pfizer, GlycoMimetics, Emmaus Medical, Bristol-Myers Squibb, CRISPR Therapeutics & Graphite Bio Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Blood Transfusion, Bone Marrow Transplant), By End-use...